29 April 2025, Mumbai: IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, announced that it has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China, for its product Ibuprofen. This approval authorizes the Company to export its Ibuprofen API to the Chinese market. Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID) known for its effectiveness […]
The post IOL Chemicals and Pharmaceuticals Limited Receives CDE Approval for Ibuprofen in China first appeared on Business News Week.